RECURRENT MIXED PHENOTYPE ACUTE LEUKEMIA
Clinical trials for RECURRENT MIXED PHENOTYPE ACUTE LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT MIXED PHENOTYPE ACUTE LEUKEMIA trials appear
Sign up with your email to follow new studies for RECURRENT MIXED PHENOTYPE ACUTE LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with aggressive blood cancers
Disease control OngoingThis early-stage study is testing a new drug called uproleselan, given with two standard chemotherapy drugs, for children and teenagers with aggressive forms of leukemia that have come back or stopped responding to treatment. The main goals are to find the safest dose and see how…
Matched conditions: RECURRENT MIXED PHENOTYPE ACUTE LEUKEMIA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New hope for babies with aggressive leukemia: targeted drug trial underway
Disease control OngoingThis study is testing whether adding a new oral drug called revumenib to standard chemotherapy is safe and effective for infants and young children with a specific, high-risk type of leukemia that has come back or hasn't responded to previous treatments. The trial aims to find th…
Matched conditions: RECURRENT MIXED PHENOTYPE ACUTE LEUKEMIA
Phase: PHASE2 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC